메뉴 건너뛰기




Volumn 8, Issue 6, 2011, Pages 2331-2338

In vivo optical imaging of membrane-type matrix metalloproteinase (MT-MMP) activity

Author keywords

activatable probe; fluorogenic probe; membrane type matrix metalloproteinase; optical imaging; protease

Indexed keywords

MATRIX METALLOPROTEINASE;

EID: 82955169662     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp2002297     Document Type: Article
Times cited : (51)

References (33)
  • 1
    • 0019195010 scopus 로고
    • Metastatic potential correlates with enzymatic degradation of basement membrane collagen
    • Liotta, L. A.; Tryggvason, K.; Garbisa, S.; Hart, I.; Foltz, C. M.; Shafie, S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen Nature 1980, 284 (5751) 67-8 (Pubitemid 10098769)
    • (1980) Nature , vol.284 , Issue.5751 , pp. 67-68
    • Liotta, L.A.1    Tryggvason, K.2    Garbisa, S.3
  • 2
    • 0036512208 scopus 로고    scopus 로고
    • New functions for the matrix metalloproteinases in cancer progression
    • Egeblad, M.; Werb, Z. New functions for the matrix metalloproteinases in cancer progression Nat. Rev. Cancer 2002, 2 (3) 161-74 (Pubitemid 37328786)
    • (2002) Nature Reviews Cancer , vol.2 , Issue.3 , pp. 161-174
    • Egeblad, M.1    Werb, Z.2
  • 3
    • 77950931419 scopus 로고    scopus 로고
    • Matrix metalloproteinases: Regulators of the tumor microenvironment
    • Kessenbrock, K.; Plaks, V.; Werb, Z. Matrix metalloproteinases: regulators of the tumor microenvironment Cell 2010, 141 (1) 52-67
    • (2010) Cell , vol.141 , Issue.1 , pp. 52-67
    • Kessenbrock, K.1    Plaks, V.2    Werb, Z.3
  • 4
    • 0037192458 scopus 로고    scopus 로고
    • Matrix metalloproteinase inhibitors and cancer: Trials and tribulations
    • DOI 10.1126/science.1067100
    • Coussens, L. M.; Fingleton, B.; Matrisian, L. M. Matrix metalloproteinase inhibitors and cancer: trials and tribulations Science 2002, 295 (5564) 2387-92 (Pubitemid 34270240)
    • (2002) Science , vol.295 , Issue.5564 , pp. 2387-2392
    • Coussens, L.M.1    Fingleton, B.2    Matrisian, L.M.3
  • 5
    • 7644224191 scopus 로고    scopus 로고
    • Extracellular proteases as targets for treatment of cancer metastases
    • DOI 10.1039/b209224g
    • Lee, M.; Fridman, R.; Mobashery, S. Extracellular proteases as targets for treatment of cancer metastases Chem. Soc. Rev. 2004, 33 (7) 401-9 (Pubitemid 39456998)
    • (2004) Chemical Society Reviews , vol.33 , Issue.7 , pp. 401-409
    • Lee, M.1    Fridman, R.2    Mobashery, S.3
  • 6
    • 33748308883 scopus 로고    scopus 로고
    • Targeting proteases: Successes, failures and future prospects
    • DOI 10.1038/nrd2092, PII NRD2092
    • Turk, B. Targeting proteases: successes, failures and future prospects Nat. Rev. Drug Discovery 2006, 5 (9) 785-99 (Pubitemid 44323703)
    • (2006) Nature Reviews Drug Discovery , vol.5 , Issue.9 , pp. 785-799
    • Turk, B.1
  • 7
    • 77955643822 scopus 로고    scopus 로고
    • Activatable molecular probes for cancer imaging
    • Lee, S.; Xie, J.; Chen, X. Activatable molecular probes for cancer imaging Curr. Top. Med. Chem. 2010, 10 (11) 1135-44
    • (2010) Curr. Top. Med. Chem. , vol.10 , Issue.11 , pp. 1135-44
    • Lee, S.1    Xie, J.2    Chen, X.3
  • 9
    • 33644545381 scopus 로고    scopus 로고
    • Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy
    • DOI 10.1038/nrc1821, PII N1821
    • Overall, C. M.; Kleifeld, O. Tumour microenvironment-opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy Nat. Rev. Cancer 2006, 6 (3) 227-39 (Pubitemid 43292566)
    • (2006) Nature Reviews Cancer , vol.6 , Issue.3 , pp. 227-239
    • Overall, C.M.1    Kleifeld, O.2
  • 10
    • 70449732503 scopus 로고    scopus 로고
    • Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer
    • Roy, R.; Yang, J.; Moses, M. A. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer J. Clin. Oncol. 2009, 27 (31) 5287-97
    • (2009) J. Clin. Oncol. , vol.27 , Issue.31 , pp. 5287-97
    • Roy, R.1    Yang, J.2    Moses, M.A.3
  • 11
    • 77749297971 scopus 로고    scopus 로고
    • Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases
    • Olson, E. S.; Jiang, T.; Aguilera, T. A.; Nguyen, Q. T.; Ellies, L. G.; Scadeng, M.; Tsien, R. Y. Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases Proc. Natl. Acad. Sci. U.S.A. 2010, 107 (9) 4311-6
    • (2010) Proc. Natl. Acad. Sci. U.S.A. , vol.107 , Issue.9 , pp. 4311-6
    • Olson, E.S.1    Jiang, T.2    Aguilera, T.A.3    Nguyen, Q.T.4    Ellies, L.G.5    Scadeng, M.6    Tsien, R.Y.7
  • 12
  • 14
    • 36148960822 scopus 로고    scopus 로고
    • Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3- methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET
    • DOI 10.1021/jm0708533
    • Wagner, S.; Breyholz, H. J.; Law, M. P.; Faust, A.; Holtke, C.; Schroer, S.; Haufe, G.; Levkau, B.; Schober, O.; Schafers, M.; Kopka, K. Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3- methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET J. Med. Chem. 2007, 50 (23) 5752-64 (Pubitemid 350106030)
    • (2007) Journal of Medicinal Chemistry , vol.50 , Issue.23 , pp. 5752-5764
    • Wagner, S.1    Breyholz, H.-J.2    Law, M.P.3    Faust, A.4    Holtke, C.5    Schroer, S.6    Haufe, G.7    Levkau, B.8    Schober, O.9    Schafers, M.10    Kopka, K.11
  • 15
    • 77957283443 scopus 로고    scopus 로고
    • In vivo evaluation of a new magnetic resonance imaging contrast agent (P947) to target matrix metalloproteinases in expanding experimental abdominal aortic aneurysms
    • Bazeli, R.; Coutard, M.; Duport, B. D.; Lancelot, E.; Corot, C.; Laissy, J. P.; Letourneur, D.; Michel, J. B.; Serfaty, J. M. In vivo evaluation of a new magnetic resonance imaging contrast agent (P947) to target matrix metalloproteinases in expanding experimental abdominal aortic aneurysms Invest. Radiol. 2010, 45 (10) 662-8
    • (2010) Invest. Radiol. , vol.45 , Issue.10 , pp. 662-8
    • Bazeli, R.1    Coutard, M.2    Duport, B.D.3    Lancelot, E.4    Corot, C.5    Laissy, J.P.6    Letourneur, D.7    Michel, J.B.8    Serfaty, J.M.9
  • 16
    • 52649167298 scopus 로고    scopus 로고
    • Activatable imaging probes with amplified fluorescent signals
    • Lee, S.; Park, K.; Kim, K.; Choi, K.; Kwon, I. C. Activatable imaging probes with amplified fluorescent signals Chem. Commun. (Cambridge) 2008, 36, 4250-60
    • (2008) Chem. Commun. (Cambridge) , vol.36 , pp. 4250-60
    • Lee, S.1    Park, K.2    Kim, K.3    Choi, K.4    Kwon, I.C.5
  • 17
    • 77952473782 scopus 로고    scopus 로고
    • Peptides and peptide hormones for molecular imaging and disease diagnosis
    • Lee, S.; Xie, J.; Chen, X. Peptides and peptide hormones for molecular imaging and disease diagnosis Chem. Rev. 2010, 110 (5) 3087-111
    • (2010) Chem. Rev. , vol.110 , Issue.5 , pp. 3087-111
    • Lee, S.1    Xie, J.2    Chen, X.3
  • 18
    • 0034954524 scopus 로고    scopus 로고
    • In vivo molecular target assessment of matrix metalloproteinase inhibition
    • DOI 10.1038/89126
    • Bremer, C.; Tung, C. H.; Weissleder, R. In vivo molecular target assessment of matrix metalloproteinase inhibition Nat. Med. 2001, 7 (6) 743-8 (Pubitemid 32588033)
    • (2001) Nature Medicine , vol.7 , Issue.6 , pp. 743-748
    • Bremer, C.1    Tung, C.-H.2    Weissleder, R.3
  • 19
    • 77749335904 scopus 로고    scopus 로고
    • Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides
    • Aguilera, T. A.; Olson, E. S.; Timmers, M. M.; Jiang, T.; Tsien, R. Y. Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides Integr. Biol. (Cambridge) 2009, 1 (5-6) 371-81
    • (2009) Integr. Biol. (Cambridge) , vol.1 , Issue.5-6 , pp. 371-81
    • Aguilera, T.A.1    Olson, E.S.2    Timmers, M.M.3    Jiang, T.4    Tsien, R.Y.5
  • 22
    • 1242343929 scopus 로고    scopus 로고
    • Development of a novel fluorogenic proteolytic beacon for in vivo detection and imaging of tumour-associated matrix metalloproteinase-7 activity
    • McIntyre, J. O.; Fingleton, B.; Wells, K. S.; Piston, D. W.; Lynch, C. C.; Gautam, S.; Matrisian, L. M. Development of a novel fluorogenic proteolytic beacon for in vivo detection and imaging of tumour-associated matrix metalloproteinase-7 activity Biochem. J. 2004, 377 (Pt 3) 617-28 (Pubitemid 38228373)
    • (2004) Biochemical Journal , vol.377 , Issue.3 , pp. 617-628
    • McIntyre, J.O.1    Fingleton, B.2    Wells, K.S.3    Piston, D.W.4    Lynch, C.C.5    Gautam, S.6    Matrisian, L.M.7
  • 24
    • 0028291737 scopus 로고
    • A matrix metalloproteinase expressed on the surface of invasive tumour cells
    • DOI 10.1038/370061a0
    • Sato, H.; Takino, T.; Okada, Y.; Cao, J.; Shinagawa, A.; Yamamoto, E.; Seiki, M. A matrix metalloproteinase expressed on the surface of invasive tumour cells Nature 1994, 370 (6484) 61-5 (Pubitemid 24216953)
    • (1994) Nature , vol.370 , Issue.6484 , pp. 61-65
    • Sato, H.1    Takino, T.2    Okada, Y.3    Cao, J.4    Shinagawa, A.5    Yamamoto, E.6    Seiki, M.7
  • 25
    • 0037426578 scopus 로고    scopus 로고
    • Membrane-type 1 matrix metalloproteinase: A key enzyme for tumor invasion
    • DOI 10.1016/S0304-3835(02)00699-7
    • Seiki, M. Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion Cancer Lett. 2003, 194 (1) 1-11 (Pubitemid 36428879)
    • (2003) Cancer Letters , vol.194 , Issue.1 , pp. 1-11
    • Seiki, M.1
  • 26
    • 34250849091 scopus 로고    scopus 로고
    • Matrix metalloproteinases: New routes to the use of MT1-MMP as a therapeutic target in angiogenesis-related disease
    • DOI 10.2174/138161207780831284
    • Arroyo, A. G.; Genis, L.; Gonzalo, P.; Matias-Roman, S.; Pollan, A.; Galvez, B. G. Matrix metalloproteinases: new routes to the use of MT1-MMP as a therapeutic target in angiogenesis-related disease Curr. Pharm. Des. 2007, 13 (17) 1787-802 (Pubitemid 46979715)
    • (2007) Current Pharmaceutical Design , vol.13 , Issue.17 , pp. 1787-1802
    • Arroyo, A.G.1    Genis, L.2    Gonzalo, P.3    Matias-Roman, S.4    Pollan, A.5    Galvez, B.G.6
  • 27
    • 66949150704 scopus 로고    scopus 로고
    • Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloproteinase: A potential role in I.p. metastatic dissemination
    • Moss, N. M.; Barbolina, M. V.; Liu, Y.; Sun, L.; Munshi, H. G.; Stack, M. S. Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloproteinase: a potential role in I.p. metastatic dissemination Cancer Res. 2009, 69 (17) 7121-9
    • (2009) Cancer Res. , vol.69 , Issue.17 , pp. 7121-9
    • Moss, N.M.1    Barbolina, M.V.2    Liu, Y.3    Sun, L.4    Munshi, H.G.5    Stack, M.S.6
  • 28
    • 0346363608 scopus 로고    scopus 로고
    • Sequence-specific silencing of MT1-MMP expression suppresses tumor cell migration and invasion: Importance of MT1-MMP as a therapeutic target for invasive tumors
    • DOI 10.1038/sj.onc.1206962
    • Ueda, J.; Kajita, M.; Suenaga, N.; Fujii, K.; Seiki, M. Sequence-specific silencing of MT1-MMP expression suppresses tumor cell migration and invasion: importance of MT1-MMP as a therapeutic target for invasive tumors Oncogene 2003, 22 (54) 8716-22 (Pubitemid 38010495)
    • (2003) Oncogene , vol.22 , Issue.54 , pp. 8716-8722
    • Ueda, J.1    Kajita, M.2    Suenaga, N.3    Fujii, K.4    Seiki, M.5
  • 31
    • 0037189494 scopus 로고    scopus 로고
    • A unique substrate binding mode discriminates membrane type-1 matrix metalloproteinase from other matrix metalloproteinases
    • DOI 10.1074/jbc.M111574200
    • Kridel, S. J.; Sawai, H.; Ratnikov, B. I.; Chen, E. I.; Li, W.; Godzik, A.; Strongin, A. Y.; Smith, J. W. A unique substrate binding mode discriminates membrane type-1 matrix metalloproteinase from other matrix metalloproteinases J. Biol. Chem. 2002, 277 (26) 23788-93 (Pubitemid 34952221)
    • (2002) Journal of Biological Chemistry , vol.277 , Issue.26 , pp. 23788-23793
    • Kridel, S.J.1    Sawai, H.2    Ratnikov, B.I.3    Chen, E.I.4    Li, W.5    Godzik, A.6    Strongin, A.Y.7    Smith, J.W.8
  • 32
    • 79959198686 scopus 로고    scopus 로고
    • Dual-functional, receptor-targeted fluorogenic probe for in vivo imaging of extracellular protease expressions
    • Zhu, L.; Xie, J.; Swierczewska, M.; Zhang, F.; Lin, X.; Fang, X.; Niu, G.; Lee, S.; Chen, X. Dual-functional, receptor-targeted fluorogenic probe for in vivo imaging of extracellular protease expressions Bioconjugate Chem. 2011, 22 (6) 1001-5
    • (2011) Bioconjugate Chem. , vol.22 , Issue.6 , pp. 1001-5
    • Zhu, L.1    Xie, J.2    Swierczewska, M.3    Zhang, F.4    Lin, X.5    Fang, X.6    Niu, G.7    Lee, S.8    Chen, X.9
  • 33
    • 47949123468 scopus 로고    scopus 로고
    • Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: Dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding
    • Butler, G. S.; Dean, R. A.; Tam, E. M.; Overall, C. M. Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding Mol. Cell. Biol. 2008, 28 (14) 4896-914
    • (2008) Mol. Cell. Biol. , vol.28 , Issue.14 , pp. 4896-914
    • Butler, G.S.1    Dean, R.A.2    Tam, E.M.3    Overall, C.M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.